Kleenex Wipes Away Kenvue’s Tears: North Texas’ Kimberly-Clark To Buy Embattled Tylenol Maker

Irving-based Kimberly-Clark snaps up Tylenol maker Kenvue in a cash-and-stock blockbuster, uniting Kleenex, Huggies, and Band ...

Kleenex parent company Kimberly-Clark buys Kenvue, maker of Tylenol, for $48.7B

Kimberly-Clark, which manufactures products like Kleenex and other products, is buying Kenvue, the maker of Tylenol, the ...
Best Media Info

Kimberly-Clark to acquire Tylenol maker Kenvue in $48.7 billion merger

The merger will bring together brands such as Huggies, Kleenex, Aveeno, and Tylenol, with Kimberly-Clark shareholders set to ...

Kimberly-Clark Is Buying Tylenol Maker Kenvue for Nearly $49B. Here's What You Need to Know

Kleenex and Cottonelle maker Kimberly-Clark said it's buying Tylenol maker Kenvue in a $48.7 billion deal. Kenvue ( KVUE) ...

Kimberly-Clark Agrees to Buy Kenvue, Maker of Tylenol, for $40 Billion

The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a ...

Kimberly-Clark Buys Embattled Tylenol Maker Kenvue In $48 Billion Deal

President Donald Trump has claimed Kenvue’s pain reliever is a potential cause of autism, despite clear evidence.

Kimberly-Clark Will Buy Tylenol Maker Kenvue in a $48.7 Billion Deal: ‘Powerful Next Step’

On Monday, Kimberly-Clark, the company behind Kleenex, Huggies and Kotex, agreed to acquire Kenvue, the owner of Tylenol, Band-Aid and Neutrogena, in a cash and stock deal valued at approximately ...

Tylenol maker Kenvue will be bought by the company behind Kleenex

Clark, whose brands include Huggies, Kleenex and Cottonelle, will own about 54 per cent of the combined company.

Irving-based Kimberly-Clark buys Tylenol maker Kenvue in $48.7 billion deal

Kimberly-Clark is making a big move with a nearly $50 billion acquisition. The North Texas company plans to acquire Kenvue ...

Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive consumer health goods company ...